Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in non-severe leptospirosis
NCT07821853Phase 2Completed
- Sponsor
- Dr. Cipto Mangunkusumo Hospital
- Start
- Aug 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in leptospirosis, sponsored by Dr. Cipto Mangunkusumo Hospital. Started Aug 2025; status: completed.
02
Drugs
acetylcysteine
03
Conditions
leptospirosis
Beyond the preview
Go deeper on NCT07821853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821853.